-
41
Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis
Published 2025-01-01Subjects: Get full text
Article -
42
DNA-mediated self-assembly oxidative damage amplifier combined with copper and MTH1 inhibitor for cancer therapy
Published 2025-03-01Subjects: Get full text
Article -
43
Machine Learning-Assisted Drug Repurposing Framework for Discovery of Aurora Kinase B Inhibitors
Published 2024-12-01Subjects: Get full text
Article -
44
Non-invasive electron paramagnetic resonance imaging detects tumor redox imbalance induced by ferroptosis
Published 2025-12-01Subjects: Get full text
Article -
45
Medication patterns and potentially inappropriate medication in patients with metastatic breast cancer: results of the BRE-BY-MED study
Published 2025-01-01Subjects: Get full text
Article -
46
Assessing hemorrhagic risks in combination therapy: implications of angiogenesis inhibitors and immune checkpoint inhibitors
Published 2025-02-01Subjects: Get full text
Article -
47
Impact of the crosstalk between the PTEN and PAFR as well as PAFR and EGFR pathways in cancer
Published 2025-01-01Subjects: Get full text
Article -
48
Epitranscriptomic RNA m6A Modification in Cancer Therapy Resistance: Challenges and Unrealized Opportunities
Published 2025-01-01Subjects: Get full text
Article -
49
Research progress of HIF-1a on immunotherapy outcomes in immune vascular microenvironment
Published 2025-02-01Subjects: Get full text
Article -
50
Leveraging Single-Cell Multi-Omics to Decode Tumor Microenvironment Diversity and Therapeutic Resistance
Published 2025-01-01Subjects: Get full text
Article -
51
iPSC Technology Revolutionizes CAR-T Cell Therapy for Cancer Treatment
Published 2025-01-01Subjects: Get full text
Article